Skip to content
Screener

Coherus BioSciences CHRS Q4 2025 Annual earnings

Reported March 9, 2026 · After market close

Revenue$12.7MMiss by $1.2M
EPS-$0.34Beat by $0.02
Revenue estimate$13.9M
EPS estimate-$0.36

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$16.0M
EPS estimate-$0.21

FAQ

When did Coherus BioSciences report Q4 2025 earnings?
Coherus BioSciences (CHRS) reported Q4 2025 earnings on March 9, 2026 after market close.
What were Coherus BioSciences's Q4 2025 revenue and EPS?
Coherus BioSciences reported revenue of $12.7M and eps of $-0.34 for Q4 2025.
Did Coherus BioSciences beat estimates in Q4 2025?
Revenue missed the consensus estimate of $13.9M by $1.2M. EPS beat the consensus estimate of $-0.36 by $0.02.
How did Coherus BioSciences's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 76.5% from $54.1M a year earlier and eps declined 21.4% from $-0.28.
Where can I find Coherus BioSciences's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-025293) and the 10-K periodic report (0001104659-26-025308) directly on SEC EDGAR. The filing index links above go to sec.gov.